# Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea

> **NCT03876717** · PHASE4 · COMPLETED · sponsor: **Lars Kristian Munck** · enrollment: 255 (actual)

## Conditions studied

- Bile Acid Malabsorption
- Chronic Diarrhea

## Interventions

- **DRUG:** Colesevelam Hydrochloride
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03876717
- **Lead sponsor:** Lars Kristian Munck
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-25
- **Primary completion:** 2021-07-01
- **Final completion:** 2022-02-13
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2022-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03876717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03876717, "Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03876717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*